The Role of the Amino Acid Hypusine in the Maintenance and Function of Tissue-Resident Macrophages
Project Number1R01AI170599-01A1
Former Number1R01AI170599-01
Contact PI/Project LeaderPEARCE, ERIKA L
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
Project Summary
Tissue-resident macrophages (TRMs) play fundamental roles in tissue homeostasis, immunity, and disease.
Thus, unlocking their biology is key to gaining a deeper knowledge of many human pathologies. TRMs are unique
from other hematopoietic cells, most of which are comparatively short-lived and continually replenished from the
bone marrow. Instead, TRMs form from yolk sac and fetal progenitors and persist into adult life through self-
renewal. Over time, and with kinetics specific to each tissue, these fetal-derived TRMs are replaced in most
tissues by bone marrow-derived monocytes, which may subsequently acquire a similar transcriptional profile to
their embryonic-derived counterparts. However, our understanding of universal factors that regulate TRMs
across tissues is limited. Cellular metabolism is one such factor that governs the differentiation trajectories of
various immune cell subsets, but how it shapes TRM differentiation, persistence, and function has yet to be
studied in detail. We previously identified polyamine metabolism, and its role in the synthesis of the amino acid
hypusine as a central axis governing macrophage metabolism and activation. We also showed that hypusine
synthesis directs the ability of T cells to take on distinct effector fates. These findings illuminated hypusine as a
focal coordinator of immune cell fate and effector programs. However, how hypusine contributes to tissue
immunity and TRM maintenance remains unknown. The sole protein to contain hypusine is the translation factor
eIF5A, in which a conserved lysine is enzymatically converted to hypusine in a two-step process via spermidine.
Hypusinated eIF5A promotes the translation of transcripts with specific sequence properties. Our goal in this
proposal is to gain deep understanding of TRM biology in homeostasis and disease by addressing hypusine
metabolism. Our central hypothesis is that hypusine regulates the differentiation of monocyte-derived cells into
TRMs and/or their maintenance in tissues, and that by targeting hypusine we can modulate macrophages to
benefit disease. We base this on our published work and striking preliminary data suggesting that hypusine
synthesis controls macrophage tissue-residency across multiple organs. Our approach will add new insight into
how short-lived precursor cells develop into long-lived TRMs that carry out functions essential for life. Importantly,
it will establish if hypusine synthesis is a tractable route to modulate TRMs in contexts where they influence
disease, such as with tumor-associated macrophages and cancer. We will test our central hypothesis by, 1)
investigating the role of hypusine synthesis in TRM formation and/or maintenance, 2) probing the mechanisms
through which hypusine governs macrophage tissue-residency, and 3) examining whether manipulating
hypusine synthesis in macrophages benefits anti-tumor immunity.
Public Health Relevance Statement
PROJECT NARRATIVE
Tissue-resident macrophages (TRMs) play fundamental roles in health and disease, thus unlocking the biology
of these cells is key to gaining a deeper knowledge of many human pathologies. This proposal’s objective is to
understand the role of the amino acid hypusine in the maintenance and function of TRMs. Our approach will add
new insight into how TRMs carry out functions essential for life, and will establish if hypusine synthesis is a
tractable route to modulate TRMs in contexts where they influence disease, such as with tumor-associated
macrophages and cancer.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
01-March-2023
Project End Date
29-February-2028
Budget Start Date
01-March-2023
Budget End Date
29-February-2024
Project Funding Information for 2023
Total Funding
$530,018
Direct Costs
$323,675
Indirect Costs
$206,343
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Allergy and Infectious Diseases
$530,018
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01AI170599-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AI170599-01A1
Patents
No Patents information available for 1R01AI170599-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AI170599-01A1
Clinical Studies
No Clinical Studies information available for 1R01AI170599-01A1
News and More
Related News Releases
No news release information available for 1R01AI170599-01A1
History
No Historical information available for 1R01AI170599-01A1
Similar Projects
No Similar Projects information available for 1R01AI170599-01A1